|
|
Previous Article | Table of Contents | Next Article 
Distribution of ligand-occupied alpha IIb beta 3 in resting and activated
human platelets determined by expression of a novel class of ligand-induced
binding site recognized by monoclonal antibody AP6
P Nurden, M Humbert, RS Piotrowicz, C Bihour, C Poujol, AT Nurden and TJ Kunicki
URA 1464 CNRS, Hopital Cardiologique, Pessac, France.
The sequence beta (3)203-228 is involved, in a yet undetermined manner, in
alpha IIb beta 3 function. We now show that murine monoclonal antibody
(MoAb) AP6, specific for beta (3)211-221, binds to alpha IIb beta 3 on
adenosine diphosphate (ADP)-activated platelets only when the receptor is
occupied by intact fibrinogen. The ligand-induced binding- site reported by
AP6 is unique in that it is not expressed following occupancy by either RGD
peptides or the gamma-chain carboxy-terminal dodecapeptide. Binding of AP6
to platelets coincides temporally with the binding of the MoAb 9F9,
specific for a receptor-induced binding site on fibrinogen. Thus, AP6
reports the binding of fibrinogen to the recognition pocket of alpha IIb
beta 3. Its binding to thrombin- stimulated washed platelets correlates
with secretion as determined using an MoAb to P-selectin. When ultrathin
sections of nonactivated platelets were examined by immunogold staining and
electron microscopy, AP6 identified a pool of alpha IIb beta 3 colocalizing
with P-selectin and suggesting the presence of alpha IIb beta 3-ligand
complexes in the alpha-granule membrane. There was little binding of AP6 to
surface alpha IIb beta 3 of unstimulated platelets. After ADP-induced
activation, AP6 was abundantly distributed over the entire platelet
surface, including pseudopods, but only when fibrinogen was present in the
medium. ADP had little effect on AP6 reactivity within platelets. This
contrasted with washed platelets and thrombin, where extensive AP6 binding
was observed within internal membrane pools as early as 10 to 15 seconds
after stimulation. Surface labeling with AP6 followed slower kinetics. Flow
cytometry on Triton X-100 permeabilized fixed platelets confirmed AP6
binding to alpha IIb beta 3 within the platelet. Thus, our results provide
evidence of (1) a pool of alpha-granule alpha IIb beta 3 occupied by ligand
in nonactivated platelets; (2) thrombin- induced activation of alpha IIb
beta 3 within the platelet, and (3) thrombin-induced mobilization of
ligand-bound alpha IIb beta 3 to the surface.
Volume 88,
Issue 3,
pp. 887-899,
08/01/1996
Copyright © 1996 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. Nurden, C. Poujol, J. Winckler, R. Combrie, N. Pousseau, P. B. Conley, S. Levy-Toledano, A. Habib, and A. T. Nurden
Immunolocalization of P2Y1 and TPalpha receptors in platelets showed a major pool associated with the membranes of alpha -granules and the open canalicular system
Blood,
February 15, 2003;
101(4):
1400 - 1408.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-F. Viallard, A. Solanilla, B. Gauthier, C. Contin, J. Dechanet, C. Grosset, J.-F. Moreau, V. Praloran, P. Nurden, J.-L. Pellegrin, et al.
Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis
Blood,
April 1, 2002;
99(7):
2612 - 2614.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Quinn, R. T. Murphy, M. Dooley, J. B. Foley, and D. J. Fitzgerald
Occupancy of the Internal and External Pools of Glycoprotein IIb/IIIa following Abciximab Bolus and Infusion
J. Pharmacol. Exp. Ther.,
April 12, 2001;
297(2):
496 - 500.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. T. Nurden, C. Poujol, C. Durrieu-Jais, and P. Nurden
Platelet Glycoprotein IIb/IIIa Inhibitors : Basic and Clinical Aspects
Arterioscler Thromb Vasc Biol,
December 1, 1999;
19(12):
2835 - 2840.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Leisner, J. D. Wencel-Drake, W. Wang, and S. C.-T. Lam
Bidirectional Transmembrane Modulation of Integrin alpha IIbbeta 3 Conformations
J. Biol. Chem.,
April 30, 1999;
274(18):
12945 - 12949.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Nurden, C. Poujol, C. Durrieu-Jais, J. Winckler, R. Combrie, L. Macchi, C. Bihour, C. Wagner, R. Jordan, and A. T. Nurden
Labeling of the Internal Pool of GP IIb-IIIa in Platelets by c7E3 Fab Fragments (abciximab): Flow and Endocytic Mechanisms Contribute to the Transport
Blood,
March 1, 1999;
93(5):
1622 - 1633.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bihour, C. Durrieu-Jais, L. Macchi, C. Poujol, P. Coste, P. Besse, P. Nurden, and A. T. Nurden
Expression of Markers of Platelet Activation and the Interpatient Variation in Response to Abciximab
Arterioscler Thromb Vasc Biol,
February 1, 1999;
19(2):
212 - 219.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Hartwig, S. Kung, T. Kovacsovics, P. A. Janmey, L. C. Cantley, T. P. Stossel, and A. Toker
D3 Phosphoinositides and Outside-in integrin Signaling by Glycoprotein IIb-IIIa Mediate Platelet Actin Assembly and Filopodial Extension Induced by Phorbol 12-Myristate 13-Acetate
J. Biol. Chem.,
December 20, 1996;
271(51):
32986 - 32993.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Humbert, P. Nurden, C. Bihour, J.-M. Pasquet, J. Winckler, E. Heilmann, P. Savi, J.-M. Herbert, T. J. Kunicki, and A. T. Nurden
Ultrastructural Studies of Platelet Aggregates From Human Subjects Receiving Clopidogrel and From a Patient With an Inherited Defect of an ADP-Dependent Pathway of Platelet Activation
Arterioscler Thromb Vasc Biol,
December 1, 1996;
16(12):
1532 - 1543.
[Abstract]
[Full Text]
|
 |
|
|
|